An experimental study of pioglitazone in treating vascular dementia
- Author:
Lu GAO
;
Ting WEI
;
Yuanyuan LU
;
Li WANG
- Publication Type:Journal Article
- Keywords:
vascular dementia;
pioglitazone;
peroxisome proliferator-activated receptor γ;
immunoenzyme staining;
immunofluorescence
- From:
Journal of Pharmaceutical Analysis
2010;22(3):179-182
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the therapeutic effects of different doses of pioglitazone, a kind of peroxisome proliferator-activated receptor γ (PPARγ) agonist, on vascular dementia and explore how pioglitazone affects cerebral ischemia. Methods Modified Pulsinelli's vessel ligation was used to establish a vascular dementia model in rats. Recognition, learning and memory were evaluated by Morris's water maze test. Immunoenzyme staining was used to determine the number of nerve cells. Immunofluorescence double-staining was used to examine the expression of PPARγ/nerve cells and PPARγ/astrocytes in different groups. Results Both in pioglitazone groups and sham-operation group, the latency was reduced significantly compared to that in control group (P<0.01). Sham-operation group had the largest number of neurons in the cortex, followed by low-dose pioglitazone group and high-dose pioglitazone group, and control group came last. Compared with control group, pioglitazone groups had more PPARγ expression in nerve cells, and the fluorescence intensity of PPARγ was stronger. Conclusion Pioglitazone can induce the expression of PPARγ in neuron endochylema and astrocyte endochylema to protect nerve cells, and then to improve spatial learning and memory function in VD rats.
